Professional Experience
- Associate Professor, Comprehensive Cancer Care Department, MMCI
- Active participant in clinical trials evaluating modern therapies for melanoma and other skin malignancies
- Member of the Czech Oncology Society’s Working Group for Skin Tumors
Academic Contributions
- Lecturer in Clinical Oncology at the Faculty of Medicine, Masaryk University
- Regular participant in national and international oncology congresses
- Contributor to the development of treatment guidelines for skin cancers in the Czech Republic
Areas of Expertise
- Systemic treatment of malignant melanoma
- Management of treatment-related adverse effects, particularly those arising from immunotherapy
- Development and implementation of treatment protocols for skin cancers
- Participation in clinical trials evaluating novel therapeutic agents for skin malignancies
Publications and Research
Dr. Lakomý has authored and co-authored several peer-reviewed journal articles, contributing significantly to the field of oncology. Notable publications include:
- 11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression – BMC Cancer, 2024
- Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma – Anticancer Research, 2017
- Adjuvant radiotherapy after brain metastasectomy: analysis of survival outcomes – Reports of Practical Oncology and Radiotherapy, 2024
Patient Care Philosophy
Dr. Lakomý emphasizes a patient-centered approach in his clinical practice. He believes in clear communication, empathy, and thorough patient education to ensure informed decision-making. His philosophy extends to international patients, offering online pre-consultations to accommodate their needs. Dr. Lakomý is also known for his cultural sensitivity, ensuring that all patients receive respectful and personalized care.
Professional Affiliations
- Czech Oncology Society
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
FAQs
- Is Dr. Lakomý board-certified?
- Yes, Dr. Lakomý is board-certified in clinical oncology and has completed habilitation and professorship procedures at Masaryk University.
- What types of surgeries does he perform?
- Dr. Lakomý specializes in the systemic treatment of skin cancers and does not perform surgical procedures. Surgical interventions are managed by his colleagues in the surgical oncology department.
- Does he treat international patients?
- Yes, Dr. Lakomý treats international patients and offers online pre-consultations to facilitate access to care.
- How long is the typical hospital stay?
- The length of hospital stay varies depending on the specific treatment regimen and patient response. Dr. Lakomý provides individualized care plans to optimize patient outcomes.
- What languages does he speak?
- Dr. Lakomý is proficient in Czech and English, enabling effective communication with a diverse patient population.
